| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.073 | 0.2 |